Prominent Medical Researcher Abandons Group Questioning Trans Health Care Safety

Trans Health Care "Skeptics" Lose Key Ally, Spark Meltdown A prominent medical researcher's departure from a group questioning the safety of trans health care has sent shockwaves through the community. Distinguished Professor Gordon Guyatt, known as the godfather of evidence-based medicine, severed ties with the Society for Evidence-Based Gender Medicine (SEGM) in August. Guyatt's departure is significant because he was one of the most influential voices associated with SEGM, a group that has cast doubt on the efficacy and safety of gender-affirming care. His involvement lent credibility to the organization's claims, which have been widely criticized by medical experts and trans advocates. "Professor Guyatt's decision to leave SEGM is a major blow to their efforts," said Dr. Marci Bowers, a renowned surgeon and advocate for trans health care. "His departure underscores the lack of scientific rigor and credibility within the organization." Guyatt, who has been a driving force behind the GRADE framework, which assesses evidence-based clinical recommendations, spoke at SEGM's 2023 conference and co-authored reviews questioning the safety of trans health care. His involvement with SEGM was seen as a departure from his usual commitment to evidence-based medicine. The Society for Evidence-Based Gender Medicine has been accused of cherry-picking data and misrepresenting scientific findings to support their claims about trans health care. Critics argue that the group's methods are flawed and lack transparency. Guyatt's decision to leave SEGM is seen as a victory for advocates of trans health care, who have long argued that the organization's views are not supported by credible evidence. "This development is a testament to the power of science and the importance of standing up against misinformation," said Dr. Bowers. "We hope this marks a turning point in the conversation around trans health care." The Society for Evidence-Based Gender Medicine has yet to comment on Guyatt's departure or its implications for their organization. However, experts predict that the group will struggle to maintain credibility without one of its most influential voices. As the debate around trans health care continues, advocates and medical professionals emphasize the importance of evidence-based research and consulting healthcare professionals when making informed decisions about one's health. "Trans individuals deserve access to safe and effective care," said Dr. Bowers. "We must prioritize science and compassion in our approach to their health." In related news, several major medical organizations have distanced themselves from SEGM, citing concerns over the group's methods and credibility. The World Health Organization (WHO) has also expressed reservations about SEGM's views on trans health care. As the situation unfolds, experts predict that Guyatt's departure will have a lasting impact on the conversation around trans health care. *Reporting by Motherjones.*